Centene's Medicare Star Ratings Slide: Only About 42% Of Members Sit In 3.5-Star Plans, Down From About 60%
The insurer also booked $263 million of severance and ended the quarter with $175 million of parent cash for general use.
Centene, which sells health insurance to low-income and underserved people through government programs and the Health Insurance Marketplace, said in its 10-Q that about 42% of its Medicare Advantage members are in plans rated 3.5 stars or higher, down from about 60% a year earlier. The same filing shows $263 million of severance for a voluntary separation program and a parent-company cash cushion that shrank to $175 million.
A rating slide that reaches 2028
CMS issued the 2027 Medicare Advantage Star Ratings in October 2026. Centene says about 42% of its Medicare Advantage members are in plans rated 3.5 stars or higher, including 10% in 4-star plans.
A year earlier the share was about 60%, including about 20% in 4-star plans. The company says the new ratings will be reflected in its 2028 plan year revenues. The prior quarter's filing carried only the 60% figure, with the 2027 plan year as its revenue year.
Medicare is the segment doing the heavy lifting this year: its third-quarter revenue rose 20% to $11.3 billion, driven by drug-plan premiums and membership, while Medicare Advantage membership fell.
A $263 million severance charge
Enterprise optimization costs, meaning vendor and severance expenses, hit $297 million in the third quarter and $358 million for the first nine months. The prior filing showed $47 million and $61 million for the three and six months.
In July the company committed to accept employees' offers to join a voluntary separation program. It recorded $263 million of severance in the quarter and paid $139 million. It expects another $50 million to $100 million for the rest of 2026, versus the $315 million to $365 million estimated in the prior filing.
Employees numbered 53,900 in the earnings release, from 59,800 in the second quarter. Centene posted a third-quarter GAAP loss of $0.14 per share and adjusted earnings of $0.58 per share, and raised its adjusted 2026 EPS floor to above $5.20.
Cash moves from stock to debt
Parent-level cash usable for general corporate purposes fell to $175 million at September 30, from $715 million at June 30; total unregulated cash dropped to $376 million from $885 million.
The company made no stock repurchases in the quarter. It bought back $558 million of senior notes and redeemed the remaining $569 million of its 2027 notes in October, leaving $1.9 billion in its debt repurchase program as of October 27.
Centene's market value was $33.6 billion as of Tuesday morning.
The Part D settlement due
Centene anticipates CMS will settle the 2025 plan year in the fourth quarter. That would also settle the $1.0 billion participating interest in Part D risk-sharing receivables it sold in March for $970 million in net proceeds.
Centene expects both settlements to land in the fourth quarter of 2026, with $2.7 billion of 2025 Part D receivables still on its balance sheet.
Sources
- 10-Q Filing — Centene (CNC) — SEC EDGAR
- 10-Q Filing — Centene (CNC), Q2 FY2026 filed 2026-07-28 (comparison basis) — SEC EDGAR
- Earnings release (8-K Item 2.02, a20261027ex991pressrelease.htm) — Centene, filed 2026-10-27 — SEC EDGAR
- Centene Corporation (CNC) Stock Price, News, Quote & History - Yahoo Finance — Yahoo Finance
- Weekly Note: Centene, Paying For 2027 And Getting 2028 For Free (NYSE:CNC) | Vasuda Healthcare Analytics | Seeking Alpha Investing Groups — seekingalpha.com
- Centene to Report Q3 Earnings: Buy, Sell or Hold the Stock? — Yahoo Finance
- How Much Should This Move Change Your View Of Centene Stock? — Yahoo Finance
- Centene, Harmony Biosciences lead list of undervalued healthcare stocks (XLV:NYSEARCA) | Seeking Alpha — seekingalpha.com